CRISPR screening in hematology research: from bulk to single-cell level
Abstract The CRISPR genome editing technology has revolutionized the way gene function is studied. Genome editing can be achieved in single genes or for thousands of genes simultaneously in sensitive genetic screens. While conventional genetic screens are limited to bulk measurements of cell behavio...
Main Authors: | Sarah Meyers, Sofie Demeyer, Jan Cools |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-023-01495-5 |
Similar Items
-
CRISPR/Cas9 in Chronic Lymphocytic Leukemia
by: María Hernández-Sánchez
Published: (2022-05-01) -
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01) -
The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
by: Jun-Zhu Chen, et al.
Published: (2023-05-01) -
Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution
by: Junyun Cheng, et al.
Published: (2023-02-01) -
Single-cell lineage tracing techniques in hematology: unraveling the cellular narrative
by: Lu-Han Deng, et al.
Published: (2025-03-01)